News Releases

LONDON, U.K AND DALLAS, TX, U.S . Spectral MD Holdings, Ltd. (AIM: SMD), a predictive analytics company with proprietary AI and optical technology for faster and more accurate treatment decisions in wound care, announces that it will now release its interim results for the six months ended 30 June

LONDON, U.K AND DALLAS, TX, U.S.  Spectral MD Holdings, Ltd. (AIM: SMD), a predictive analytics company with proprietary AI and optical technology for faster and more accurate treatment decisions in wound care, announces that the Notice of Annual General Meeting (“AGM”) and Form of Proxy will

Spectral MD Awarded an Additional $8.2M of Funding from BARDA | SpectralMD Skip to content SpectralMD Main Menu Investors Blog     Search About Show submenu Mission, Vision, and Values Leadership Team Careers Contact Why It Matters Show submenu Burn Diabetic Foot Ulcer (DFU) Technology Show submenu

LONDON, U.K AND DALLAS, TX, U.S.  – Spectral MD Holdings, Ltd. (AIM: SMD), a predictive analytics company that develops proprietary AI algorithms and optical technology for faster and more accurate treatment decisions in wound care, announces that it has granted options (“Options”) over a total of

LONDON, U.K AND DALLAS, TX, U.S.  Spectral MD Holdings, Ltd. (AIM: SMD), a predictive analytics company that develops proprietary AI algorithms and optical technology for faster and more accurate treatment decisions in wound care, announces that it has obtained a waiver for the Mandatory Takeover

LONDON, U.K AND DALLAS, TX, U.S.  Spectral MD Holdings, Ltd. (AIM: SMD), a predictive analytics company that develops proprietary AI algorithms and optical technology for faster and more accurate treatment decisions in wound care, announces that restrictive legends have today been removed from the

Spectral MD win Best Technology award at the European Mediscience Awards LONDON, U.K AND DALLAS, TX, U.S. Spectral MD Holdings, Ltd. (AIM: SMD), a predictive analytics company that develops proprietary AI algorithms and optical technology for faster and more accurate treatment decisions in wound

Validation study to assess up to 200 adult subjects with participation from leading U.S. principal investigators LONDON, U.K AND DALLAS, TX, U.S.  Spectral MD Holdings, Ltd. (AIM: SMD), a predictive analytics company that develops proprietary AI algorithms and optical technology for faster and more

LONDON, U.K AND DALLAS, TX, U.S.  Spectral MD Holdings, Ltd. (AIM: SMD), a predictive analytics company that develops proprietary AI algorithms and optical technology for faster and more accurate treatment decisions in wound care, announces that the Annual Report and Accounts are now available on

Seasoned marketing & commercialisation professional to help bolster commercialisation expertise LONDON, U.K AND DALLAS, TX, U.S.  Spectral MD Holdings, Ltd. (AIM: SMD), a predictive analytics company that develops proprietary AI algorithms and optical technology for faster and more accurate